- Print Friendly - Help

AVMAC Update

The third meeting of the Agricultural Compounds and Veterinary Medicines Advisory Council (AVMAC) was held on 12 May 1998. A full report of this meeting (and past meetings) is available.

The main issues for discussion were:

• Quality control under the ACVM Act

  Chris Boland presented a paper covering the proposed principles for placing conditions on the registration of trade name products governing quality characteristics.

• Cost recovery

  The latest version of the paper covering suggested principles and practices for cost recovery under the ACVM Act was presented by Bruce Burdon (MAF Policy). This document will be edited and circulated for comment; there will be consultation on the cost details for the regulations.

• Risk assessment of agricultural compounds
  for the purposes of exemption from registration

  Nick Whelan, John Reeve and Chris Boland covered the outcomes from the four AVMAC working parties (Animals, Plants, Fertilisers and Animal Feeds). Once comments have been taken into account, these outcomes will be developed into regulations which will be circulated for further consultation. Many thanks to all of the industry people who helped in the process.

• Review of MAF Reg ACVM Group strategic direction

  Tim Knox proposed setting up an AVMAC working group to review any changes that need to be considered in the next ACVM Group strategic plan. Colin Harvey (ARPPA), Graham Pinnell (Federated Farmers), Chris Kelly (NZ Dairy Board), and Jack Richardson (AGCARM) will form the working party.

• Compliance under the ACVM Act

  Brian Pidford gave the meeting an update of the key issues from the submissions received on this paper. The compliance policy is being reviewed and we are working on clarifying the off-label issue.

Other agenda items included the presentation of the draft MRL process by John Reeve and the development of the new regulatory approval process by Kieran Galvin.

The next meeting is planned for 19 August, but there will be significant communication with the AVMAC group in the interim as a key part of the consultation process.